drugset / Trial / NCT05534750

Evaluation of the Early Bactericidal Activity of Tedizolid and Linezolide Against Mycobacterium Tuberculosis (TEDITUB)

NCT05534750

Phase 2 Recruiting 60 enrolled Assistance Publique - Hôpitaux de Paris
RandomizedParallel-groupOpen-labelTreatment

Summary

The objective of this work is to measure the early bactericidal activity of tedizolid, to compare it with the bactericidal activity of linezolid (reference molecule for the treatment of multidrug-resistant tuberculosis) and with that of standard quadruple therapy (reference treatment of drug susceptible tuberculosis).

Timeline

Start
2023-04-20
Primary completion
2026-04
Completion
2026-05

Drugs

EvaluationDrugModalityDoseRoute
Comparator Ethambutol Small molecule
Comparator Isoniazid Small molecule 5 mg/kg
Subject Linezolid Other / unclassified 600 mg
Comparator Pyrazinamide Small molecule
Comparator Rifampin Small molecule 10 mg/kg
Subject Tedizolid Small molecule 200 mg